Atricure Inc. buy Needham & Company LLC
Start price
13.02.25
/
50%
€29.29
Target price
13.02.26
€49.06
Performance (%)
16.08%
Price
30.12.25
€34.00
Summary
This prediction is currently active. The prediction currently has a performance of 16.08%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Needham___Company_LL at any time. Needham___Company_LL has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Atricure Inc. | -2.857% | -2.857% |
| iShares Core DAX® | 0.869% | 3.389% |
| iShares Nasdaq 100 | -0.852% | -2.157% |
| iShares Nikkei 225® | 0.436% | 1.060% |
| iShares S&P 500 | -0.122% | -0.270% |
Comments by Needham___Company_LL for this prediction
In the thread Atricure Inc. diskutieren
AtriCure, Inc. (NASDAQ: ATRC) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $51.00 price target on the stock.
Ratings data for ATRC provided by MarketBeat